Cyclosporin A induces peritoneal fibrosis and angiogenesis during chronic peritoneal exposure to a glucose-based, lactate-buffered dialysis solution in the rat.

PubWeight™: 0.98‹?› | Rank: Top 15%

🔗 View Article (PMID 18087149)

Published in Blood Purif on December 14, 2007

Authors

Roos van Westrhenen1, Jan Aten, Najat Hajji, Onno J de Boer, Cindy Kunne, Dirk R de Waart, Raymond T Krediet

Author Affiliations

1: Department of Nephrology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Articles by these authors

Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions. Nat Med (2013) 4.22

A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant (2003) 2.95

High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients. Nephrol Dial Transplant (2007) 2.91

Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study. Nephrol Dial Transplant (2010) 2.64

Estimation of residual glomerular filtration rate in dialysis patients from the plasma cystatin C level. Nephrol Dial Transplant (2007) 2.53

The effect of contraindications and patient preference on dialysis modality selection in ESRD patients in The Netherlands. Am J Kidney Dis (2004) 2.40

Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver. J Clin Invest (2012) 2.33

Time-dependent reasons for peritoneal dialysis technique failure and mortality. Perit Dial Int (2010) 2.17

Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int (2002) 2.12

Pharmacological inhibition of glucosylceramide synthase enhances insulin sensitivity. Diabetes (2007) 2.01

Computed tomographic findings characteristic for encapsulating peritoneal sclerosis: a case-control study. Perit Dial Int (2009) 1.96

Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients. Nephrol Dial Transplant (2010) 1.90

CCR5 deletion protects against inflammation-associated mortality in dialysis patients. J Am Soc Nephrol (2009) 1.88

Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: a randomized controlled trial. Kidney Int (2003) 1.87

Analysis of the prevalence and causes of ultrafiltration failure during long-term peritoneal dialysis: a cross-sectional study. Perit Dial Int (2004) 1.86

Social support predicts survival in dialysis patients. Nephrol Dial Transplant (2006) 1.84

Early diagnostic markers for encapsulating peritoneal sclerosis: a case-control study. Perit Dial Int (2010) 1.82

Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients. Nephrol Dial Transplant (2006) 1.76

Blood pressure influences end-stage renal disease of Cd151 knockout mice. J Clin Invest (2011) 1.75

Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis. PLoS One (2010) 1.73

Dietary protein requirements and dialysate protein losses in chronic peritoneal dialysis patients. Perit Dial Int (2007) 1.71

Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport. Hepatology (2006) 1.71

Direct intestinal cholesterol secretion contributes significantly to total fecal neutral sterol excretion in mice. Gastroenterology (2007) 1.69

The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD )-2. Am J Kidney Dis (2003) 1.66

Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis. Am J Kidney Dis (2002) 1.62

Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. J Am Soc Nephrol (2004) 1.62

The Kidney Disease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: association with mortality in dialysis patients. Am J Kidney Dis (2005) 1.60

Evaluation of a new immortalized human fetal liver cell line (cBAL111) for application in bioartificial liver. J Hepatol (2007) 1.55

How to adjust for comorbidity in survival studies in ESRD patients: a comparison of different indices. Am J Kidney Dis (2002) 1.49

Hemodialysis and peritoneal dialysis: comparison of adjusted mortality rates according to the duration of dialysis: analysis of The Netherlands Cooperative Study on the Adequacy of Dialysis 2. J Am Soc Nephrol (2003) 1.48

Effects of icodextrin on the peritoneal membrane. Nephrol Dial Transplant (2010) 1.48

Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition. J Ren Nutr (2009) 1.46

Encapsulating peritoneal sclerosis: the state of affairs. Nat Rev Nephrol (2011) 1.44

Overexpression of activated protein C is detrimental during severe experimental gram-negative sepsis (melioidosis). Crit Care Med (2013) 1.43

Noncanonical NF-kappaB signaling in dendritic cells is required for indoleamine 2,3-dioxygenase (IDO) induction and immune regulation. Blood (2007) 1.42

Differential expression of interleukin-17 family cytokines in intact and complicated human atherosclerotic plaques. J Pathol (2010) 1.39

Fluid loss does not explain coagulation activation during air travel. Thromb Haemost (2008) 1.38

The MDRD formula does not reflect GFR in ESRD patients. Nephrol Dial Transplant (2010) 1.38

Organic anion transporting polypeptide 1a/1b-knockout mice provide insights into hepatic handling of bilirubin, bile acids, and drugs. J Clin Invest (2010) 1.37

Guideline on targets for solute and fluid removal in adult patients on chronic peritoneal dialysis. Perit Dial Int (2006) 1.33

Mice lacking Mrp3 (Abcc3) have normal bile salt transport, but altered hepatic transport of endogenous glucuronides. J Hepatol (2005) 1.29

Damage of the endothelial glycocalyx in dialysis patients. J Am Soc Nephrol (2012) 1.29

Altered disposition of acetaminophen in mice with a disruption of the Mrp3 gene. Hepatology (2005) 1.28

Association between a self-rated health question and mortality in young and old dialysis patients: a cohort study. Am J Kidney Dis (2008) 1.27

Ultrasensitive in situ visualization of active glucocerebrosidase molecules. Nat Chem Biol (2010) 1.26

Expression of activation-induced cytidine deaminase is confined to B-cell non-Hodgkin's lymphomas of germinal-center phenotype. Cancer Res (2003) 1.23

Full loss of residual renal function causes higher mortality in dialysis patients; findings from a marginal structural model. Nephrol Dial Transplant (2011) 1.22

The transcriptomic signature of fasting murine liver. BMC Genomics (2008) 1.19

CTGF inhibits BMP-7 signaling in diabetic nephropathy. J Am Soc Nephrol (2008) 1.19

Association between body mass index and mortality is similar in the hemodialysis population and the general population at high age and equal duration of follow-up. J Am Soc Nephrol (2007) 1.18

A mouse genetic model for familial cholestasis caused by ATP8B1 mutations reveals perturbed bile salt homeostasis but no impairment in bile secretion. Hum Mol Genet (2004) 1.18

Adjustment for comorbidity in studies on health status in ESRD patients: which comorbidity index to use? J Am Soc Nephrol (2003) 1.16

Connective tissue growth factor and igf-I are produced by human renal fibroblasts and cooperate in the induction of collagen production by high glucose. Diabetes (2003) 1.16

Activity of the bile salt export pump (ABCB11) is critically dependent on canalicular membrane cholesterol content. J Biol Chem (2009) 1.14

Bone alkaline phosphatase and mortality in dialysis patients. Clin J Am Soc Nephrol (2011) 1.13

Increased expression of T cell activation markers (CD25, CD26, CD40L and CD69) in atherectomy specimens of patients with unstable angina and acute myocardial infarction. Atherosclerosis (2003) 1.12

Does the biocompatibility of the peritoneal dialysis solution matter in assessment of peritoneal function? Perit Dial Int (2007) 1.11

Adeno-associated virus vector serotypes mediate sustained correction of bilirubin UDP glucuronosyltransferase deficiency in rats. Mol Ther (2006) 1.11

Modulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in mice. Hepatology (2009) 1.09

Trimestral variations of C-reactive protein, interleukin-6 and tumour necrosis factor-α are similarly associated with survival in haemodialysis patients. Nephrol Dial Transplant (2010) 1.09

Effects of muscarinic receptor stimulation on Ca2+ transient, cAMP production and pacemaker frequency of rabbit sinoatrial node cells. Basic Res Cardiol (2009) 1.08

CD44 deficiency increases tubular damage but reduces renal fibrosis in obstructive nephropathy. J Am Soc Nephrol (2004) 1.08

Reducing glycosphingolipid content in adipose tissue of obese mice restores insulin sensitivity, adipogenesis and reduces inflammation. PLoS One (2009) 1.08

Complementary functions of the flippase ATP8B1 and the floppase ABCB4 in maintaining canalicular membrane integrity. Gastroenterology (2011) 1.07

Impact of Abcc2 (Mrp2) and Abcc3 (Mrp3) on the in vivo elimination of methotrexate and its main toxic metabolite 7-hydroxymethotrexate. Clin Cancer Res (2008) 1.07

Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice. Am J Physiol Renal Physiol (2005) 1.06

Microalbuminuria in adults after prenatal exposure to the Dutch famine. J Am Soc Nephrol (2004) 1.06

Blood pressure response to uncomplicated hemodialysis: the importance of changes in stroke volume. Nephron Clin Pract (2004) 1.06

Microvascular proliferation in congenital vascular malformations of skin and soft tissue. J Clin Pathol (2006) 1.05

Abcg5/8 independent biliary cholesterol excretion in Atp8b1-deficient mice. Gastroenterology (2008) 1.04

Survival in dialysis patients is not different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition. BMC Nephrol (2011) 1.04

Local treatment with the selective IkappaB kinase beta inhibitor NEMO-binding domain peptide ameliorates synovial inflammation. Arthritis Res Ther (2006) 1.04

Lipopolysaccharide inhibits Th2 lung inflammation induced by house dust mite allergens in mice. Am J Respir Cell Mol Biol (2012) 1.04

Quantification of free water transport in peritoneal dialysis. Kidney Int (2004) 1.03

Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients. Nephrol Dial Transplant (2008) 1.03

A positive effect of AII inhibitors on peritoneal membrane function in long-term PD patients. Nephrol Dial Transplant (2008) 1.02

Functionally overlapping roles of Abcg2 (Bcrp1) and Abcc2 (Mrp2) in the elimination of methotrexate and its main toxic metabolite 7-hydroxymethotrexate in vivo. Clin Cancer Res (2009) 1.01

Effect of an increase in C-reactive protein level during a hemodialysis session on mortality. J Am Soc Nephrol (2004) 1.00

When to start dialysis treatment: where do we stand? Perit Dial Int (2005) 1.00

Determinants of peritoneal solute transport rates in newly started nondiabetic peritoneal dialysis patients. Perit Dial Int (2004) 1.00

Peritoneal albumin and protein losses do not predict outcome in peritoneal dialysis patients. Clin J Am Soc Nephrol (2010) 0.99

Kupffer cells and not liver sinusoidal endothelial cells prevent lentiviral transduction of hepatocytes. Mol Ther (2005) 0.98

Inefficient chronic activation of parietal cells in Ae2a,b(-/-) mice. Am J Pathol (2006) 0.98

Connective tissue growth factor (CTGF/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate. Am J Physiol Renal Physiol (2009) 0.97

Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters. Am J Nephrol (2007) 0.97

Low cholesterol in dialysis patients--causal factor for mortality or an effect of confounding? Nephrol Dial Transplant (2011) 0.96

Symptom clusters in incident dialysis patients: associations with clinical variables and quality of life. Nephrol Dial Transplant (2008) 0.96

Sex differences in the impact of diabetes on mortality in chronic dialysis patients. Nephrol Dial Transplant (2010) 0.96

Human renal epithelial cells produce the long pentraxin PTX3. Kidney Int (2005) 0.96

Mycophenolate mofetil attenuates plaque inflammation in patients with symptomatic carotid artery stenosis. Atherosclerosis (2010) 0.96

Peritoneal effluent markers of inflammation in patients treated with icodextrin-based and glucose-based dialysis solutions. Adv Perit Dial (2003) 0.96

Dextran antibodies in peritoneal dialysis patients treated with icodextrin. Perit Dial Int (2002) 0.96

Amelioration of arthritis by intraarticular dominant negative Ikk beta gene therapy using adeno-associated virus type 5. Hum Gene Ther (2006) 0.95

Trans-intestinal cholesterol efflux is not mediated through high density lipoprotein. J Lipid Res (2012) 0.95

Connective tissue growth factor participates in scar formation of crescentic glomerulonephritis. Lab Invest (2003) 0.95